Structures by: Viswanathan V.
Total: 54
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(4-methoxyphenyl)acetamide
C13H15N5O2S
IUCrData (2018) 3, 4 x180600
a=18.2763(6)Å b=7.5909(2)Å c=20.0571(6)Å
α=90° β=90° γ=90°
Ethyl 4-(furan-2-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
C12H14N2O4
IUCrData (2016) 1, 12 x161937
a=7.4670(2)Å b=8.8307(3)Å c=10.5426(3)Å
α=106.833(2)° β=108.557(2)° γ=99.420(2)°
<i>N</i>-[(3-Bromo-1-phenylsulfonyl-1<i>H</i>-indol-2-yl)methyl]-4-fluoroaniline
C21H16BrFN2O2S
IUCrData (2017) 2, 2 x170147
a=8.1732(5)Å b=10.5828(7)Å c=12.1781(8)Å
α=113.6990(10)° β=94.6170(10)° γ=99.2030(10)°
2-(4-Chlorophenyl)-15-hydroxy-4-methyl-4,18-diazaoctacyclo[14.11.1.1^6,10^.0^1,5^.0^5,15^.0^17,26^.0^19,24^.0^14,29^]nonacosa-6,8,10(29),11,13,17,19(24),20,22,25-decaen-27-one methanol hemisolvate
C34H25ClN2O2,0.5(CH4O)
IUCrData (2016) 1, 4 x160637
a=10.3848(3)Å b=10.4306(3)Å c=14.4513(4)Å
α=69.3940(10)° β=72.3880(10)° γ=70.8710(10)°
6b-Hydroxy-17-methyl-15-(3-nitrophenyl)-6b,7,16,17-tetrahydro-7,14a-methanonaphtho[1',8':1,2,3]pyrrolo[3',2':8,8a]azuleno[5,6-<i>b</i>]quinolin-14(15<i>H</i>)-one dichloromethane hemisolvate
C34H25N3O4,0.5(CH2Cl2)
IUCrData (2016) 1, 5 x160828
a=9.3566(3)Å b=12.1189(4)Å c=12.7055(4)Å
α=94.490(2)° β=93.300(2)° γ=107.5540(10)°
<i>N</i>,<i>N</i>-Diethyl-2-[5-(4-methoxybenzylidene)-2,4-dioxo-1,3-thiazolidin-3-yl]acetamide
C17H20N2O4S
IUCrData (2017) 2, 5 x170716
a=11.6978(6)Å b=7.1331(4)Å c=21.1822(12)Å
α=90° β=95.311(4)° γ=90°
1,4-Bis[(oxan-2-yl)oxy]benzene
C16H22O4
IUCrData (2017) 2, 5 x170717
a=6.767(5)Å b=6.817(5)Å c=15.864(5)Å
α=90.000° β=99.391(5)° γ=90.000°
Imidazolium diphenylacetate diphenylacetic acid
(C14H12O2)(C14H11O2)(C3H5N2)
New Journal of Chemistry (2018) 42, 4 2439
a=6.0295(3)Å b=9.1751(5)Å c=11.9172(7)Å
α=94.105(4)° β=100.519(4)° γ=96.335(4)°
Isonicotinamidium picrate
C12H9N5O8
RSC Adv. (2016) 6, 63 57977
a=14.290(5)Å b=7.430(5)Å c=14.697(5)Å
α=90.000(5)° β=116.638(5)° γ=90.000(5)°
Benzimidazole Phthalamide compound
C23H17N5O6
RSC Adv. (2016)
a=8.5032(5)Å b=12.9483(7)Å c=18.8575(11)Å
α=90.00° β=98.797(3)° γ=90.00°
C45H50Cl2CuN6O9
C45H50Cl2CuN6O9
Dalton transactions (Cambridge, England : 2003) (2016) 45, 18 7794-7814
a=16.0226(4)Å b=16.0226(4)Å c=34.0974(12)Å
α=90° β=90° γ=120°
6-(Naphthalen-1-yl)-6a-nitro-6,6a,6b,7,9,11a-hexahydrospiro[chromeno[3',4':3,4]pyrrolo[1,2-<i>c</i>]thiazole-11,11'-indeno[1,2-<i>b</i>]quinoxaline]
C37H26N4O3S
Acta Crystallographica Section E (2019) 75, 10 1519-1524
a=8.3690(3)Å b=13.2440(4)Å c=29.2210(5)Å
α=90° β=93.280(2)° γ=90°
6'-(nNphthalen-1-yl)-6a'-nitro-6',6a',6b',7',8',9',10',12a'-octahydro-2<i>H</i>-spiro[acenaphthylene-1,12'-chromeno[3,4-<i>a</i>]indolizin]-2-one
C36H28N2O4
Acta Crystallographica Section E (2019) 75, 10 1519-1524
a=35.7360(5)Å b=11.4510(4)Å c=15.3130(3)Å
α=90° β=98.378(2)° γ=90°
(<i>E</i>)-4-{1-[2-(Carbamothioyl)hydrazin-1-ylidene]ethyl}phenyl 4-methylbenzoate
C17H17N3O2S
Acta Crystallographica Section E (2015) 71, 1 o43-o44
a=8.068(5)Å b=14.037(5)Å c=15.221(5)Å
α=99.801(5)° β=96.040(5)° γ=98.533(5)°
2-{[(Naphthalen-1-yl)oxy]methyl}-5-(2,4,5-trifluorophenyl)-1,3,4-oxadiazole
C19H11F3N2O2
Acta Crystallographica Section E (2015) 71, 3 o190-o191
a=7.4817(5)Å b=7.5928(5)Å c=15.7908(10)Å
α=78.673(3)° β=78.404(3)° γ=65.370(3)°
2-(4-Fluoro-3-methylphenyl)-5-{[(naphthalen-1-yl)oxy]methyl}-1,3,4-oxadiazole
C20H15FN2O2
Acta Crystallographica Section E (2015) 71, 4 o229-o230
a=7.4236(4)Å b=7.5062(4)Å c=16.3519(8)Å
α=77.092(3)° β=77.494(3)° γ=66.734(3)°
(<i>E</i>)-4-[1-(2-Carbamothioylhydrazinylidene)ethyl]phenyl acetate
C11H13N3O2S
Acta Crystallographica Section E (2017) 73, 1 20-23
a=7.8783(2)Å b=8.9254(3)Å c=18.7372(5)Å
α=77.243(2)° β=82.423(2)° γ=78.856(2)°
(<i>E</i>)-4-[1-(2-Carbamothioylhydrazinylidene)ethyl]phenyl benzoate
C16H15N3O2S
Acta Crystallographica Section E (2017) 73, 1 20-23
a=7.8145(4)Å b=9.7538(5)Å c=10.9050(7)Å
α=78.855(4)° β=69.031(2)° γ=84.200(3)°
<i>N</i>-(4-Chlorophenyl)-2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]acetamide
C12H12ClN5OS
Acta Crystallographica Section E (2017) 73, 4 467-471
a=18.2743(12)Å b=7.4835(5)Å c=19.8021(12)Å
α=90° β=90° γ=90°
<i>N</i>-(3-Chlorophenyl)-2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]acetamide
C12H12ClN5OS
Acta Crystallographica Section E (2017) 73, 4 467-471
a=18.220(2)Å b=8.1180(12)Å c=19.628(2)Å
α=90° β=108.761(8)° γ=90°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(naphthalen-1-yl)acetamide
C16H15N5OS
Acta Crystallographica Section E (2017) 73, 2 306-309
a=25.1895(16)Å b=6.9411(4)Å c=8.9697(6)Å
α=90° β=90.943(4)° γ=90°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(4-fluorophenyl)acetamide
C12H12FN5OS
Acta Crystallographica Section E (2017) 73, 2 306-309
a=21.7358(7)Å b=7.3726(3)Å c=8.4487(3)Å
α=90° β=93.0920(10)° γ=90°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(pyridin-2-yl)acetamide
C11H12N6OS
Acta Crystallographica Section E (2018) 74, 5 718-723
a=7.2341(2)Å b=9.3852(2)Å c=9.7971(2)Å
α=95.8200(10)° β=91.1160(10)° γ=105.6820(10)°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(pyrazin-2-yl)acetamide
C10H11N7OS
Acta Crystallographica Section E (2018) 74, 5 718-723
a=12.1333(5)Å b=8.1561(3)Å c=12.8442(5)Å
α=90° β=94.307(3)° γ=90°
2-(4-{2-[(2-Oxo-2<i>H</i>-chromen-4-yl)oxy]acetyl}piperazin-1-yl)acetamide
C17H19N3O5
Acta Crystallographica Section E (2019) 75, 4 482-488
a=8.5260(3)Å b=8.8415(3)Å c=11.9462(4)Å
α=88.660(2)° β=69.568(2)° γ=70.724(2)°
<i>N</i>-(2,4-Dimethoxybenzyl)-2-[(2-oxo-2<i>H</i>-chromen-4-yl)oxy]acetamide
C20H19NO6
Acta Crystallographica Section E (2019) 75, 4 482-488
a=7.2779(2)Å b=8.5759(3)Å c=14.4099(5)Å
α=90° β=93.796(5)° γ=90°
6-(4-Chlorophenyl)-6a-nitro-6a,6b,8,9,10,12a-hexahydro-6<i>H</i>,7<i>H</i>-spiro[chromeno[3,4-<i>a</i>]indolizine-12,11'-indeno[1,2-<i>b</i>]quinoxaline]
C35H27ClN4O3
Acta Crystallographica Section E (2019) 75, 2 255-259
a=14.18800(10)Å b=23.4450(3)Å c=18.3710(2)Å
α=90° β=104.541(2)° γ=90°
6'-(4-Chlorophenyl)-6a'-nitro-6a',6b',7',9',10',12a'-hexahydro-2<i>H</i>,6'<i>H</i>,8'<i>H</i>-spiro[acenaphthylene-1,12'-chromeno[3,4-<i>a</i>]indolizin]-2-one
C32H25ClN2O4
Acta Crystallographica Section E (2019) 75, 2 218-222
a=10.6777(4)Å b=11.6095(4)Å c=12.6037(8)Å
α=98.383(3)° β=105.378(3)° γ=115.522(2)°
6'-(4-Methoxyphenyl)-6a'-nitro-6a',6b',7',9',10',12a'-hexahydro-2<i>H</i>,6'<i>H</i>,8'<i>H</i>-spiro[acenaphthylene-1,12'-chromeno[3,4-<i>a</i>]indolizin]-2-one
C33H28N2O5
Acta Crystallographica Section E (2019) 75, 2 218-222
a=19.8942(2)Å b=13.6097(7)Å c=20.78220(10)Å
α=90° β=107.268(3)° γ=90°
4,4'-{[1,3-Phenylenebis(methylene)]bis(oxy)}bis(3-methoxybenzaldehyde)
C24H22O6
Acta Crystallographica Section E (2019) 75, 6 875-879
a=11.7026(3)Å b=14.6628(4)Å c=12.7512(3)Å
α=90° β=107.863(2)° γ=90°
4,4'-{[(1,4-Phenylenebis(methylene)]bis(oxy)}bis(3-methoxybenzaldehyde)
C24H22O6
Acta Crystallographica Section E (2019) 75, 6 875-879
a=12.6668(5)Å b=7.7470(3)Å c=10.4244(4)Å
α=90° β=102.126(2)° γ=90°
4-(5-Acetamido-3-acetyl-2-methyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)phenyl benzoate
C20H19N3O4S
Acta Crystallographica Section E (2019) 75, 10 1436-1444
a=6.75590(10)Å b=16.9258(2)Å c=19.0611(3)Å
α=110.4470(10)° β=96.854(2)° γ=93.3700(10)°
4-(5-Acetamido-3-acetyl-2-methyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)phenyl isobutyrate 0.25-hydrate
C17H21N3O4S,0.25(H2O)
Acta Crystallographica Section E (2019) 75, 10 1436-1444
a=6.78020(10)Å b=17.2671(4)Å c=17.3089(4)Å
α=108.2240(10)° β=99.0840(10)° γ=96.7200(10)°
4-(5-Acetamido-3-acetyl-2-methyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)phenyl propionate
C16H19N3O4S
Acta Crystallographica Section E (2019) 75, 10 1436-1444
a=11.4150(3)Å b=12.4021(3)Å c=13.2305(3)Å
α=71.9820(10)° β=89.8290(10)° γ=83.1140(10)°
4-(5-Acetamido-3-acetyl-2-methyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)phenyl cinnamate chloroform hemisolvate
C22H21N3O4S,0.5(CHCl3)
Acta Crystallographica Section E (2019) 75, 10 1436-1444
a=10.74270(10)Å b=11.0828(2)Å c=20.8969(3)Å
α=93.1860(10)° β=103.945(4)° γ=98.489(2)°
2-[(2-Oxo-2<i>H</i>-chromen-4-yl)oxy]acetic acid dimethyl sulfoxide monosolvate
C11H8O5,C2H6OS
Acta Crystallographica Section E (2019) 75, 8 1123-1127
a=23.1461(12)Å b=8.2631(4)Å c=14.6374(8)Å
α=90° β=97.687(4)° γ=90°
8-Amino-6-methyl-3,4-diphenyl-1<i>H</i>-isochromen-1-one
C22H17NO2
Acta Crystallographica Section E (2019) 75, 8 1117-1122
a=9.1652(3)Å b=16.9764(6)Å c=10.9687(4)Å
α=90° β=91.1560(10)° γ=90°
8-Amino-3,4-diethyl-6-methyl-1<i>H</i>-isochromen-1-one
C14H17NO2
Acta Crystallographica Section E (2019) 75, 8 1117-1122
a=10.4844(8)Å b=26.562(2)Å c=9.3651(6)Å
α=90° β=105.367(3)° γ=90°
6-(4-Chlorophenyl)-6a-nitro-6,6a,6b,7,9,11a-hexahydrospiro[chromeno[3,4':3,4]\ pyrrolo[1,2-<i>c</i>]thiazole-11,11'-indeno[1,2-<i>b</i>]quinoxaline] chloroform solvate
C33H23ClN4O3S1,CHCl3
Acta Crystallographica Section E (2014) 70, 10 o1111-o1112
a=8.983(5)Å b=13.241(5)Å c=14.269(5)Å
α=99.890(5)° β=99.204(5)° γ=105.519(5)°
6-Ferrocenyl-6a'-nitro-6',6a',6b',7',9',11a'-hexahydro-2<i>H</i>-\ spiro[acenaphthylene-1,11'-chromeno[3',4':3,4]pyrrolo[1,2-<i>c</i>]thiazol]-\ 2-one
C34H26FeN2O4S
Acta Crystallographica Section E (2016) 72, 8 1126-1129
a=11.782(5)Å b=16.741(5)Å c=14.147(5)Å
α=90.00° β=98.013(5)° γ=90.00°
6'-(4-Methoxyphenyl)-6a'-nitro-6',6a',6b',7',9',11a'-hexahydro-2<i>H</i>-spiro[acenaphthylene-1,11'-chromeno[3',4':3,4]pyrrolo[1,2-<i>c</i>]thiazol]-2-one
C31H24N2O5S
Acta Crystallographica Section E (2016) 72, 8 1126-1129
a=11.1123(5)Å b=11.6373(2)Å c=12.4095(3)Å
α=117.8120(10)° β=110.8120(10)° γ=95.4680(10)°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(2,4-dimethylphenyl)acetamide
C14H17N5OS
Acta Crystallographica Section E (2017) 73, 7 996-1000
a=23.7716(6)Å b=7.0073(2)Å c=9.0909(2)Å
α=90° β=90.086(2)° γ=90°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(3-methoxyphenyl)acetamide
C13H15N5O2S
Acta Crystallographica Section E (2017) 73, 7 996-1000
a=8.014(5)Å b=8.724(5)Å c=12.068(5)Å
α=106.561(5)° β=97.888(5)° γ=110.461(5)°
4'-(2-Methoxyquinolin-3-yl)-1'-methyldispiro[indan-2,2'-pyrrolidine-3',3''-indoline]-1,3,2''-trione
C30H23N3O4
Acta Crystallographica Section E (2015) 71, 12 o1038-o1039
a=10.9058(3)Å b=9.5178(5)Å c=23.8651(6)Å
α=90.00° β=95.378(2)° γ=90.00°
Ethyl 6-methyl-2-sulfanylidene-4-(thiophen-2-yl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate
C12H14N2O2S2
Acta Crystallographica Section E (2015) 71, 2 o81-o82
a=7.30690(10)Å b=8.32670(10)Å c=11.24610(10)Å
α=90.1090(10)° β=95.1560(10)° γ=101.2760(10)°
4,11-Dihydroxy-13-methyl-1,8-di-<i>p</i>-tolyl-2,9-dithia-13-azadispiro[4.1.4^7^.3^5^]tetradecan-6-one
C26H31NO3S2
Acta Crystallographica Section E (2015) 71, 12 1516-1520
a=10.7160(8)Å b=8.5570(5)Å c=25.6960(3)Å
α=90.00° β=92.374(5)° γ=90.00°
13-Benzyl-4,11-dihydroxy-1,8-bis(4-methylphenyl)-2,9-dithia-13-azadispiro[4.1.4^7^.3^5^]tetradecan-6-one
C32H35NO3S2
Acta Crystallographica Section E (2015) 71, 12 1516-1520
a=9.9803(6)Å b=11.7773(8)Å c=13.6506(14)Å
α=105.524(5)° β=107.215(5)° γ=103.087(4)°
15-(2-Chlorophenyl)-6b-hydroxy-17-methyl-6b,7,16,17-tetrahydro-7,14a-methanonaphtho[1',8':1,2,3]pyrrolo[3',2':8,8<i>a</i>]azuleno[5,6-<i>b</i>]quinolin-14(15<i>H</i>)-one
C34H25ClN2O2
Acta Crystallographica Section E (2015) 71, 12 o1091-o1092
a=11.1328(2)Å b=13.0756(3)Å c=19.0866(4)Å
α=90° β=103.7380(10)° γ=90°
(<i>Z</i>)-1^5^-Bromo-3^2^,3^2^-dimethyl-2^1^-nitro-2^2^,2^3^,2^5^,2^6^,2^7^,2^7a^,3^3a^,3^5^,3^6^,3^6a^-decahydro-2^1^<i>H</i>,6^1^<i>H</i>-4,9-dioxa-2(3,2)-pyrrolizina-6(4,1)-triazola-3(5,6)-furo[2,3-<i>d</i>][1,3]dioxola-1(1,2)-benzenacyclononaphane
C25H29BrN5O7
Acta Crystallographica Section E (2015) 71, 7 827-831
a=9.913(5)Å b=11.414(5)Å c=12.144(5)Å
α=90° β=99.903(5)° γ=90°
(<i>Z</i>)-3^2^,3^2^-Dimethyl-2^7^-nitro-2^5^,2^6^,2^7^,2^7a^,3^3a^,3^5^,3^6^,3^6a^-octahydro-2^1^<i>H</i>,2^3^<i>H</i>,6^1^<i>H</i>-4,9-dioxa-2(5,6)-pyrrolo[1,2-<i>c</i>]thiazola-6(4,1)-triazola-3(5,6)-furo[2,3-<i>d</i>][1,3]dioxola-1(1,2)-benzenacyclononaphane
C24H29N5O7S
Acta Crystallographica Section E (2015) 71, 7 827-831
a=8.756(5)Å b=10.811(5)Å c=13.569(5)Å
α=90° β=101.122(5)° γ=90°
Ethyl 6-chloromethyl-2-oxo-4-(2,3,4-trimethoxyphenyl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate
C17H21ClN2O6
Acta Crystallographica Section E (2015) 71, 7 821-823
a=9.479(5)Å b=10.080(5)Å c=10.320(5)Å
α=108.552(5)° β=102.886(5)° γ=94.406(5)°
Amide Cyclophane
C32H30N4O2S2
Acta Crystallographica Section E (2014) 70, 8 o865
a=23.0760(5)Å b=9.9380(3)Å c=27.0341(7)Å
α=90.00° β=108.428(2)° γ=90.00°
(<i>E</i>)-1-(5-Iodothiophen-2-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
C16H15IO4S
Acta Crystallographica Section E (2012) 68, 10 o2921
a=17.2328(12)Å b=8.1885(6)Å c=23.7049(17)Å
α=90.00° β=90.00° γ=90.00°
4-Acetylphenyl 3-methylbenzoate
C16H14O3
Acta Crystallographica Section E (2014) 70, 9 o1060
a=8.7167(3)Å b=9.8521(3)Å c=15.4938(4)Å
α=90.00° β=95.149(2)° γ=90.00°